HEAD RX
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions RUB (ex. Per Share) | FY202312/31/2023 | FY202412/31/2024 | ||
|---|---|---|---|---|
| Revenue | 29,449.1 | 39,618.9 | ||
| -Cost of Revenue | 814.1 | 1,186.3 | ||
| Gross Profit | 28,635.0 | 38,432.6 | ||
| -Operating Expenses | 12,833.4 | 18,131.3 | ||
| +Selling, General & Admin | 11,668.0 | 16,872.4 | ||
| +General And Administrative Expenses | 8,460.0 | 11,781.6 | ||
| +Selling And Marketing Expenses | 3,208.1 | 5,090.7 | ||
| +Research and Development | - | - | ||
| +Other Operating Expenses | 1,165.4 | 1,259.0 | ||
| Operating Income | 15,801.6 | 20,301.3 | ||
| +Non Operating Income | 1,614.8 | 6,862.5 | ||
| +Interest Income, Net | 193.6 | 2,683.6 | ||
| +Interest Income | 829.7 | 3,131.2 | ||
| -Interest Expense | 636.1 | 447.5 | ||
| +Other Non-Op Income | 1,421.3 | 4,178.8 | ||
| Pretax Income | 17,222.9 | 24,480.1 | ||
| -Income Tax Expense | 4,828.6 | 598.3 | ||
| Income from Cont Ops | 12,394.3 | 23,881.8 | ||
| -Net Extraordinary Losses | - | - | ||
| +Discounted operations | - | - | ||
| +XO & Accounting Changes | - | - | ||
| Income Incl. MI | 12,394.3 | 23,881.8 | ||
| -Minority Interests | 4,178.5 | 5,485.6 | ||
| Net Income, GAAP | 8,215.9 | 18,396.2 | ||
| -Prfrrd Div & Other | - | - | ||
| Net Income Avail To Common | 8,215.9 | 18,396.2 | ||
| Weighted Average Shs Out | 33,878,911 | 38,876,607 | ||
| EPS | 242.5 | 473.2 | ||
| Weighted Average Shs Out Dil | 33,878,911 | 39,168,275 | ||
| EPS Diluted | 242.5 | 469.7 | ||
| Millions RUB (ex. Per Share) | FY202312/31/2023 | FY202412/31/2024 | ||
|---|---|---|---|---|
| Revenue | 29,449.1 | 39,618.9 | ||
| -Cost of Revenue | 814.1 | 1,186.3 | ||
| Gross Profit | 28,635.0 | 38,432.6 | ||
| -Operating Expenses | 12,833.4 | 18,131.3 | ||
| +Selling, General & Admin | 11,668.0 | 16,872.4 | ||
| +General And Administrative Expenses | 8,460.0 | 11,781.6 | ||
| +Selling And Marketing Expenses | 3,208.1 | 5,090.7 | ||
| +Research and Development | - | - | ||
| +Other Operating Expenses | 1,165.4 | 1,259.0 | ||
| Operating Income | 15,801.6 | 20,301.3 | ||
| +Non Operating Income | 1,614.8 | 6,862.5 | ||
| +Interest Income, Net | 193.6 | 2,683.6 | ||
| +Interest Income | 829.7 | 3,131.2 | ||
| -Interest Expense | 636.1 | 447.5 | ||
| +Other Non-Op Income | 1,421.3 | 4,178.8 | ||
| Pretax Income | 17,222.9 | 24,480.1 | ||
| -Income Tax Expense | 4,828.6 | 598.3 | ||
| Income from Cont Ops | 12,394.3 | 23,881.8 | ||
| -Net Extraordinary Losses | - | - | ||
| +Discounted operations | - | - | ||
| +XO & Accounting Changes | - | - | ||
| Income Incl. MI | 12,394.3 | 23,881.8 | ||
| -Minority Interests | 4,178.5 | 5,485.6 | ||
| Net Income, GAAP | 8,215.9 | 18,396.2 | ||
| -Prfrrd Div & Other | - | - | ||
| Net Income Avail To Common | 8,215.9 | 18,396.2 | ||
| Weighted Average Shs Out | 33,878,911 | 38,876,607 | ||
| EPS | 242.5 | 473.2 | ||
| Weighted Average Shs Out Dil | 33,878,911 | 39,168,275 | ||
| EPS Diluted | 242.5 | 469.7 | ||